Bauxite

Queensland Bauxite Ltd (ASX:QBL) Cover Letter for 3B 19th March 2018

🕔3/20/2018 9:54:36 AM

The Board of Queensland Bauxite (ASX:QBL) is pleased to advise that it has cleared the company's outstanding debt by way of share issue.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Half Year Report

🕔3/19/2018 8:51:50 AM

The Directors present their report on Queensland Bauxite Limited, consisting of Queensland Bauxite Limited (ASX:QBL) and the entities it controlled at the end of or during the half-year ended 31 December 2017.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) A World First for MCL in Autoimmune Disease Research

🕔2/26/2018 9:49:17 AM

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its subsidiary company Medical Cannabis Limited through its wholly owned subsidiary Medical Cannabis Research Group Pty Ltd, has signed a Research Funding Agreement with the Research & Development Foundation at the Technion Institute, Haifa, Israel.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report

🕔2/1/2018 8:27:51 AM

Queensland Bauxite Limited (ASX:QBL) provides the Company's Quarterly Activities Report.

Read Full Article

Australian Bauxite Ltd (ASX:ABX) Quarterly Report and Activities Statement

🕔1/31/2018 9:27:23 AM

Australian Bauxite Ltd (ASX:ABX) provides the Company's Quarterly Report and Activities Statement for the period ending 31 December, 2017.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) John Easterling -Amazon John- to Join Board of MCL

🕔1/18/2018 8:55:18 AM

I am delighted and proud on behalf of the Board of Queensland Bauxite Limited (ASX:QBL) to inform our shareholders that Mr John Easterling has agreed to join the board of our Cannabis subsidiary Medical Cannabis Limited.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) MCL Leads in Medical Cannabis with Canadian Deal

🕔1/9/2018 8:30:54 AM

The Board of Queensland Bauxite Ltd (ASX:QBL) is thrilled to be involved in bringing to Australia, through its subsidiary MCL, a fundamentally new product in the world cannabis market, and especially in the Australian market that should be one that will be accepted by the medical industry at large due to the unique benefits and advantages enumerated below.

Read Full Article